Literature DB >> 31097157

10-Year Risk Equations for Incident Heart Failure in the General Population.

Sadiya S Khan1, Hongyan Ning2, Sanjiv J Shah3, Clyde W Yancy3, Mercedes Carnethon2, Jarett D Berry4, Robert J Mentz5, Emily O'Brien5, Adolfo Correa6, Navin Suthahar7, Rudolf A de Boer7, John T Wilkins8, Donald M Lloyd-Jones8.   

Abstract

BACKGROUND: Primary prevention strategies to mitigate the burden of heart failure (HF) are urgently needed. However, no validated risk prediction tools are currently in use.
OBJECTIVES: This study sought to derive 10-year risk equations of developing incident HF.
METHODS: Race- and sex-specific 10-year risk equations for HF were derived and validated from individual-level data from 7 community-based cohorts with at least 12 years of follow-up. Participants who were recruited between 1985 and 2000, between 30 to 79 years, and were free of cardiovascular disease at baseline were included to create a pooled cohort (PC) and were randomly split for derivation and internal validation. Model performance was also assessed in 2 additional cohorts.
RESULTS: In the derivation sample of the PC (n = 11,771), 58% were women, 22% were black with a mean age of 52 ± 12 years, and HF occurred in 1,339 participants. Predictors of HF included in the race-sex-specific models were age, blood pressure (treated or untreated), fasting glucose (treated or untreated), body mass index, cholesterol, smoking status, and QRS duration. The PC equations to Prevent HF model had good discrimination and strong calibration in internal and external validation cohorts. A web-based tool was developed to facilitate clinical application of this tool.
CONCLUSIONS: The authors present a contemporary analysis from 33,010 men and women demonstrating the utility of the sex- and race-specific 10-year PC equations to Prevent HF risk score, which integrates clinical parameters readily available in primary care settings. This tool can be useful in risk-based decision making to determine who may merit intensive screening and/or targeted prevention strategies.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  epidemiology; heart failure; primary prevention; risk factor

Mesh:

Year:  2019        PMID: 31097157      PMCID: PMC6527121          DOI: 10.1016/j.jacc.2019.02.057

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  52 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study.

Authors:  Herman A Taylor; James G Wilson; Daniel W Jones; Daniel F Sarpong; Asoka Srinivasan; Robert J Garrison; Cheryl Nelson; Sharon B Wyatt
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

4.  Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]).

Authors:  G F Diercks; W M Janssen; A J van Boven; A A Bak; P E de Jong; H J Crijns; W H van Gilst
Journal:  Am J Cardiol       Date:  2000-09-15       Impact factor: 2.778

Review 5.  ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  Sharon Ann Hunt
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

6.  Profile for estimating risk of heart failure.

Authors:  W B Kannel; R B D'Agostino; H Silbershatz; A J Belanger; P W Wilson; D Levy
Journal:  Arch Intern Med       Date:  1999-06-14

7.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

Review 8.  The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.

Authors:  Thomas J Wang; Daniel Levy; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Ann Intern Med       Date:  2003-06-03       Impact factor: 25.391

9.  Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

Authors:  Ramachandran S Vasan; Emelia J Benjamin; Martin G Larson; Eric P Leip; Thomas J Wang; Peter W F Wilson; Daniel Levy
Journal:  JAMA       Date:  2002-09-11       Impact factor: 56.272

10.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

View more
  37 in total

1.  Heart Failure Risk Distribution and Trends in the United States Population, NHANES 1999-2016.

Authors:  Peter A Glynn; Hongyan Ning; Aakash Bavishi; Priya M Freaney; Sanjiv Shah; Clyde W Yancy; Donald M Lloyd-Jones; Sadiya S Khan
Journal:  Am J Med       Date:  2020-08-20       Impact factor: 4.965

2.  Validation of Heart Failure-Specific Risk Equations in 1.3 Million Israeli Adults and Usefulness of Combining Ambulatory and Hospitalization Data from a Large Integrated Health Care Organization.

Authors:  Sadiya S Khan; Noam Barda; Philip Greenland; Noa Dagan; Donald M Lloyd-Jones; Ran Balicer; Laura J Rasmussen-Torvik
Journal:  Am J Cardiol       Date:  2022-01-12       Impact factor: 2.778

Review 3.  Contemporary Review of Risk Scores in Prediction of Coronary and Cardiovascular Deaths.

Authors:  Jose B Cruz Rodriguez; Khan O Mohammad; Haider Alkhateeb
Journal:  Curr Cardiol Rep       Date:  2022-01-27       Impact factor: 2.931

4.  Development and Validation of a Long-Term Incident Heart Failure Risk Model.

Authors:  Sadiya S Khan; Hongyan Ning; Norrina B Allen; Mercedes R Carnethon; Clyde W Yancy; Sanjiv J Shah; John T Wilkins; Lu Tian; Donald M Lloyd-Jones
Journal:  Circ Res       Date:  2021-12-10       Impact factor: 17.367

5.  Predictive Accuracy of Heart Failure-Specific Risk Equations in an Electronic Health Record-Based Cohort.

Authors:  Aakash Bavishi; Matthew Bruce; Hongyan Ning; Priya M Freaney; Peter Glynn; Faraz S Ahmad; Clyde W Yancy; Sanjiv J Shah; Norrina B Allen; Suma X Vupputuri; Laura J Rasmussen-Torvik; Donald M Lloyd-Jones; Sadiya S Khan
Journal:  Circ Heart Fail       Date:  2020-10-23       Impact factor: 8.790

6.  Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score.

Authors:  Matthew W Segar; Muthiah Vaduganathan; Kershaw V Patel; Darren K McGuire; Javed Butler; Gregg C Fonarow; Mujeeb Basit; Vaishnavi Kannan; Justin L Grodin; Brendan Everett; Duwayne Willett; Jarett Berry; Ambarish Pandey
Journal:  Diabetes Care       Date:  2019-09-13       Impact factor: 19.112

Review 7.  Risk-Based Approach for the Prediction and Prevention of Heart Failure.

Authors:  Arjun Sinha; Deepak K Gupta; Clyde W Yancy; Sanjiv J Shah; Laura J Rasmussen-Torvik; Elizabeth M McNally; Philip Greenland; Donald M Lloyd-Jones; Sadiya S Khan
Journal:  Circ Heart Fail       Date:  2021-02-04       Impact factor: 8.790

8.  Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management.

Authors:  Hersh Shroff; Lisa B VanWagner
Journal:  Curr Hepatol Rep       Date:  2020-06-29

9.  Refocusing on the Primary Prevention of Heart Failure.

Authors:  Lua A Jafari; Rachel M Suen; Sadiya S Khan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-05-29

10.  Age-Related Development of Cardiac Remodeling and Dysfunction in Young Black and White Adults: The Coronary Artery Risk Development in Young Adults Study.

Authors:  Amanda M Perak; Sadiya S Khan; Laura A Colangelo; Samuel S Gidding; Anderson C Armstrong; Cora E Lewis; Jared P Reis; Pamela J Schreiner; Stephen Sidney; Joao A C Lima; Donald M Lloyd-Jones
Journal:  J Am Soc Echocardiogr       Date:  2020-11-17       Impact factor: 5.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.